LONGEVITY OF RABIES ANTIBODY TITER IN RECIPIENTS OF HUMAN-DIPLOID CELL RABIES VACCINE

被引：38
|
作者：
BRIGGS, DJ [1 ]
SCHWENKE, JR [1 ]
机构：
[1] KANSAS STATE UNIV AGR & APPL SCI,DEPT STAT,MANHATTAN,KS 66506
来源：
VACCINE | 1992年 / 10卷 / 02期
关键词：
RABIES; VACCINE; INTRAMUSCULAR; INTRADERMAL; LONGEVITY;
D O I：
10.1016/0264-410X(92)90029-J
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Sera from individuals across the USA and Peace Corps Volunteers (PCV) were assayed for neutralizing antibody to human diploid cell rabies vaccine (HDCV). A pairwise comparison between intramuscular (i.m.) and intradermal (i.d.) administration, PCV and non-PCV, revealed statistically significant differences between i.m. and i.d. for PCV and non-PCV, and between PCV and non-PCV for i.d. and i.m. administration. Survival analysis and frequency tables employing chi(2) tests determined that the percentage probability of maintaining an adequate titre from 1.5-2.0 years after primary vaccination was 99% in non-PCV i.m., 93% in non-PCV i.d., 88% in PCV i.m., and 64% in PCV i.d.
引用
收藏
页码：125 / 129
页数：5
相关论文
共 50 条
  • [1] RESPONSES TO HUMAN-DIPLOID CELL RABIES VACCINE - NEUTRALIZING ANTIBODY-RESPONSES OF VACCINEES RECEIVING BOOSTER DOSES OF HUMAN-DIPLOID CELL RABIES VACCINE
    ROSANOFF, E
    TINT, H
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1979, 110 (03) : 322 - 327
  • [2] Safety and immunogenicity of Lyssavac Berna human diploid cell rabies vaccine in healthy adults
    Briggs, DJ
    Dreesen, DW
    Morgan, P
    Chin, JE
    Seedle, CD
    Cryz, L
    Gluck, R
    Cryz, SJ
    VACCINE, 1996, 14 (14) : 1361 - 1365
  • [3] Antibody persistence, 32 years after post-exposure prophylaxis with human diploid cell rabies vaccine (HDCV)
    Fayaz, Ahmad
    Simani, Susan
    Janani, Alireza
    Farahtaj, Firouzeh
    Biglari, Peyvand
    Howeizi, Nader
    Eslami, Nasser
    VACCINE, 2011, 29 (21) : 3742 - 3745
  • [4] Safety and immunogenicity of a serum-free purified Vero rabies vaccine in comparison with the rabies human diploid cell vaccine (HDCV; Imovax® Rabies) administered in a simulated rabies post-exposure regimen in healthy adults
    Pichon, Sylvie
    Moureau, Annick
    Petit, Celine
    Kirstein, Judith L.
    Sheldon, Eric
    Guinet-Morlot, Francoise
    Minutello, Ada-Maria
    VACCINE, 2024, 42 (10) : 2553 - 2559
  • [5] Improved serological response to human diploid cell rabies vaccine when given simultaneously with antirabies hyperimmune globulin
    Navarrete-Navarro, S
    Aguilar-Setién, A
    Avila-Figueroa, C
    Hernández-Sierra, F
    Santos-Preciado, JI
    ARCHIVES OF MEDICAL RESEARCH, 1999, 30 (04): : 332 - 337
  • [6] Acute motor axonal neuropathy following anti-rabies human diploid cell vaccine: A rare case and review
    Chawla, Tanushree
    Sehgal, Jyoti
    Dabla, Surekha
    Goyal, Vinay
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2022, 15 (09) : 425 - 426
  • [7] Acute motor axonal neuropathy following anti-rabies human diploid cell vaccine: A rare case and review
    Tanushree Chawla
    Jyoti Sehgal
    Surekha Dabla
    Vinay Goyal
    Asian Pacific Journal of Tropical Medicine, 2022, 15 (09) : 425 - 426
  • [8] Purified Chick Embryo Cell Culture Rabies Vaccine: interchangeability with Human Diploid Cell Culture Rabies Vaccine and comparison of one versus two-dose post-exposure booster regimen for previously immunized persons
    Briggs, DJ
    Dreesen, DW
    Nicolay, U
    Chin, JE
    Davis, R
    Gordon, C
    Banzhoff, A
    VACCINE, 2000, 19 (9-10) : 1055 - 1060
  • [9] ANTIBODY TITER AFTER ANTI-IDIOTYPE RABIES VACCINATION WITH NANO-CHITOSAN ADJUVANT
    Paryati, Sayu Putu Yuni
    Ramadhanti, S.
    Hasan, K.
    INFEKTSIYA I IMMUNITET, 2024, 14 (04):
  • [10] Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses
    Brookes, SM
    Parsons, G
    Johnson, N
    McElhinney, LM
    Fooks, AR
    VACCINE, 2005, 23 (32) : 4101 - 4109
12345